Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Zaeck, Luca MTan, Ngoc H
Rietdijk, Wim JR
Geers, Daryl
Sablerolles, Roos SG
Bogers, Susanne
van Dijk, Laura LA
Gommers, Lennert
van Leeuwen, Leanne PM
Rugebregt, Sharona
Goorhuis, Abraham
Postma, Douwe F
Visser, Leo G
Dalm, Virgil ASH
Lafeber, Melvin
Kootstra, Neeltje A
Huckriede, Anke LW
Haagmans, Bart L
van Baarle, Debbie
Koopmans, Marion PG
van der Kuy, P Hugo M
GeurtsvanKessel, Corine H
de Vries, Rory D
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boostersPublished in
Nat Commun 2024;15(1):4224PMID
38762522ae974a485f413a2113503eed53cd6c53
10.1038/s41467-024-48414-x
Scopus Count
Collections